Healthcare
CICC commits $286m to China's Concord Medical
CICC Capital, the private equity arm of China International Capital Corp, has agreed to invest up to RMB1.8 billion ($286 million) in an onshore subsidiary of Concord Medical, a US-listed healthcare business that abandoned a management-led privatization...
Riverside secures exits in New Zealand, Australia
The Riverside Company has sold New Zealand-based animal health devices manufacturer Simcro, along with Work Health Group, an occupational rehabilitation services provider in Australia.
PE-owned Qualitas Medical targets Singapore IPO
Southern Capital Group is making another attempt to list Qualitas Medical, its Malaysia-based healthcare services provider, on the Singapore Stock Exchange. Partners Group is also an investor in the business.
China's CMAB Biopharma gets $34m Series B
CD Capital, a Chinese healthcare-focused VC also known as CDBI Partners, has led a $34 million Series B round for CMAB Biopharma, a manufacturing services provider for biologic product developers.
Tencent leads $80m round for China's Miaoshou Doctor
Tencent Holdings has led a RMB500 million ($80 million) Series C round for Miaoshou Doctor, a China-based healthcare services provider.
VCs back $60m round for US, China-based Singlera Genomics
Chinese VCs Green Pine Capital Partners and Prosperico Ventures have led a $60 million Series A investment in US and China-based cancer diagnosis specialist Singlera Genomics.
Sequoia leads $50m round for China's Adagene
Sequoia Capital China has led an oversubscribed $50 million Series C funding round for Chinese biotechnology company Adagene.
China's Hua Medicine gets $117m
Hua Medicine, a Chinese clinical-stage biotechnology company, has closed a combined Series D and Series E funding round at $117.4 million with support from a group of VCs.
IMM secures 2x return on Korea pharma investments
IMM Private Equity has fully exited its investments in Korean pharmaceutical developers Handok and Genexine.
Yunfeng, Alibaba agree $1.4b iKang take-private
The protracted pursuit of Chinese healthcare services provider iKang Healthcare Group appears to have ended, with Yunfeng Capital and Alibaba Group agreeing to buy the business at a valuation of around $1.4 billion.
VCs in $47m round for Chinese AI medical imaging firm
Beijing Infervision, a Chinese company that develops medical imaging technology empowered by artificial intelligence (AI), has raised RMB300 million ($47 million) in funding from investors including Xianghe Capital.
ChrysCapital invests $20m in India's Curatio
ChrysCapital has invested $20 million in Indian skin and hair products producer Curatio, providing a partial exit for its private equity backer Fulcrum Ventures.
Cathay Capital, OrbiMed sell Echosens stakes to Astorg
Cathay Capital Private Equity and OrbiMed have exited Echosens, a France-based medical diagnostic equipment company owned by China’s Inner Mongolia FuRui Medical Science, to European PE firm Astorg.
Tikehau makes $50m first close on Singapore healthcare fund
European asset management firm Tikehau Capital has reached a first close of $50 million on a healthcare-focused early stage investment fund.
Hong Kong IPOs: Open season
Hong Kong is proposing to loosen its listing requirements - with a view to attracting Chinese technology IPOs - in a measured way. However, changes of such significance are rarely implemented smoothly
China's JW Therapeutics gets $90m Series A round
JW Therapeutics, a China-based clinical stage biopharmaceutical company, has raised $90 million in a Series A round of funding led by Temasek Holdings, Sequoia Capital China, and Yuan Ming Capital.
Traditional Chinese medicine: Innovating antiquity
As the time-honored but largely unprofessional industry of traditional Chinese medicine reinvents itself for the 21st century, private equity could play a role in a massive healthcare overhaul
Matrix backs China consumer-focused genetic testing player
Matrix Partners China has led a RMB100 million ($15.8 million) round for 23Mofang, a Chinese genetic testing services provider.
HDFC joins Series C for India's MedGenome
Indian listed financial institution HDFC has joined the Series C round for MedGenome, an India and US-based company focused on molecular biology research and diagnostics.
Samena, Cenova in $83m round for Hong Kong's Virtus Medical
Virtus Medical Holdings, a Hong Kong-based private medical services provider, has raised an $83 million round of funding from Samena Capital and Cenova Capital.
Chinese GPs back AstraZeneca spin-out
A consortium led by Boyu Capital, 6 Dimensions Capital and Hillhouse Capital will invest up to $250 million in Viela Bio, a pharmaceutical research and development company being spun out from AstraZeneca.
Abraaj founder steps back as part of governance review
Arif Naqvi, founder of The Abraaj Group, has stepped back from the fund management business as part of changes to the firm’s governance and operating model. This comes after LPs expressed concerns that a healthcare fund had been misused.
Australia's Foundry invests in Welleco
The Foundry, a private equity firm launched by executives from vitamin producer Swisse Wellness, has acquired a 25% stake in Welleco, a dietary supplement maker co-founded by supermodel Elle Macpherson (pictured).
Yunfeng, MicroPort agree international medical devices carve-out
Chinese PE firm Yunfeng Capital and Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation will acquire US-listed LivaNova's cardiac rhythm management (CRM) business for $190 million in cash.